#USA #New York #Securities Fraud #Pomerantz LLP #Fulgent Genetics

Pomerantz Law Firm Investigates Fulgent Genetics

Pomerantz LLP, a leading law firm specializing in class action litigation, is actively investigating claims on behalf of investors of Fulgent Genetics, Inc. (NASDAQ: FLGT). This notice aims to inform shareholders of potential legal actions due to alleged securities fraud and other misconduct involving the company.

On February 28, 2025, Fulgent released its annual report to the U.S. Securities and Exchange Commission, disclosing that it had received a civil investigative demand from the U.S. Department of Justice. This demand relates to potential false claims submitted to the Uninsured Program. Such revelations raised alarm bells among investors, resulting in a notable decline in the company's stock price. In fact, within two trading sessions following the announcement, Fulgent's share value dropped by $0.41, equating to a 2.61% loss, closing at $15.28 per share by March 3, 2025.

What This Means for Investors

For investors holding Fulgent stock, this situation could present significant implications. The investigation focuses on whether the company and its executives have participated in unlawful business practices, which could constitute securities fraud. It is essential for affected investors to be aware of their rights and options moving forward.

Pomerantz LLP encourages investors who have experienced losses in their investment in Fulgent to reach out for assistance. Danielle Peyton, an attorney at the firm, can be contacted at [Danielle Peyton's email] or via phone at 646-581-9980, ext. 7980. By doing so, investors can explore the possibility of joining a class-action lawsuit, which could alleviate personal damages suffered due to this alleged fraud.

About Pomerantz LLP

For over 85 years, Pomerantz LLP has been recognized as a premier law firm that fights for the rights of victims affected by securities fraud and corporate misconduct. Founded by Abraham L. Pomerantz, known as the dean of the class action bar, the firm has recovered billions in damages for class members through its dedication to pursuing justice.

With offices in major cities such as New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, Pomerantz is strategically equipped to handle complex cases across various jurisdictions. The firm prides itself on its extensive experience in corporate, securities, and antitrust class litigation, making it a formidable advocate for investors seeking redress.

Join the Investigation

Investors who believe they have been impacted by Fulgent's actions are encouraged to act promptly. Legal proceedings can be time-sensitive, and seeking representation from Pomerantz LLP may be a critical step towards obtaining potential compensation for losses incurred.

This investigation is a reminder for all investors to remain vigilant and informed about the companies they invest in, especially when facing unexpected disclosures that may signal deeper issues.

For more information and to stay updated on this developing situation, please follow [Pomerantz's official website]

Disclaimer: This announcement is not a solicitation for a class action. Prior results do not guarantee similar outcomes and all claims are subject to applicable laws and regulations.